Danaher Corp (NYSE:DHR)
$ 234.34 -1.57 (-0.67%) Market Cap: 170.39 Bil Enterprise Value: 181.11 Bil PE Ratio: 45.02 PB Ratio: 3.32 GF Score: 87/100

Danaher Corp at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 06:10PM GMT
Release Date Price: $212.91 (-0.02%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Welcome, everybody. My name is Matt Sykes. I'm the senior life science tools and diagnostics analyst at Goldman Sachs. Today, we have the pleasure of having Matt McGrew, the Executive Vice President and Chief Financial Officer; and Matt Gugino, the Head of Investor Relations from Danaher. I guess you have to be named Matt to be part of this panel. So I'm glad we all made it in.

Questions & Answers

Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

But maybe Matt McGrew, I will start with you and just kind of maybe let you set the stage, talk a little bit about the recent quarter, some of the key drivers you see over the course of this year and kind of your views today.

Matthew R. McGrew
Danaher Corporation - CFO & Executive VP

Sure. So I mean I think maybe just kind of revisiting Q1 just to get people sort of grounded a little bit. We had a pretty good start to the year here in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot